Ownes & Minor (NYSE: OMI) reported Q3 EPS of $0.42, $0.05 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $2.39 billion versus the consensus estimate of $2.33 billion.

“We are very pleased with the strong growth we are seeing in our top line, which we believe is a result of our strategic approach to the market, as well as the improving healthcare environment,” said James L. Bierman, president & chief executive officer of Owens & Minor. “In the coming months, we will be fully engaged with the integration of the previously announced Medical Action acquisition, as well as the pending ArcRoyal acquisition. We are enthusiastic about the new and broader capabilities that these transactions will enable us to bring to our customers.”

For earnings history and earnings-related data on Ownes & Minor (OMI) click here.